US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.3450
  • -0.0090-2.54%
Close Nov 27 16:00 ET
  • 0.3697
  • +0.0247+7.16%
Post 20:01 ET
2.17MMarket Cap-12P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cyclacel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 25.000K--
--2024/Q4-- / 10.000K--
--2024/Q310.000K / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 25.000K--
--2024/Q4-- / 10.000K--
--2024/Q310.000K / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--

Unlock Free Earnings Estimates

Cyclacel Pharmaceuticals Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 12 17:14 ET

  • 8-K: Cyclacel Pharmaceuticals Reports THIRD quarter financial results and provides business update

    Nov 12 17:04 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 17:10 ET

  • 8-K: Cyclacel Pharmaceuticals Reports SECOND quarter financial results and provides business update

    Aug 14 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data